Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 19(3): e0297644, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38507340

RESUMO

Climate change challenges countries around the world, and news media are key to the public's awareness and perception of it. But how are news media approaching climate change across countries? With the problem of climate change and its solution being global, it is key to determine whether differences in climate change news reports exist and what they are across countries. This study employs supervised machine learning to uncover topical and terminological differences between newspaper articles on climate change. An original dataset of climate change articles is presented, originating from 7 newspapers and 3 countries across the world, and published in English during 26 Conference of the Parties (COP) meetings from the United Nations Framework Convention on Climate Change (UNFCC). Three aspects are used to discriminate between articles, being (1) countries, (2) political orientations, and (3) COP meetings. Our results reveal differences with regard to how newspaper articles approach climate change globally. Specifically, climate change-related terminology of left-oriented newspapers is more prevalent compared to their right-oriented counterparts. Also, over the years, newspapers' climate change-related terminology has evolved to convey a greater sense of urgency.


Assuntos
Mudança Climática , Meios de Comunicação de Massa , Relatório de Pesquisa , Nações Unidas
2.
Berl Munch Tierarztl Wochenschr ; 124(1-2): 83-8, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21306059

RESUMO

The pharmacokinetic properties of marbofoxacin, a third generation fluoroquinolone, were investigated in 12 healthy adult cats after single subcutaneous (SC) administration of 2 mg/kg BW (Part I, n=8 cats) and 4 mg/kg BW (Part II, n=4 cats). In each part of the study blood and urine samples were collected before treatment and thereafter for 5 days. The plasma and urine concentrations of marbofloxacin were determined by HPLC with UV detection. Pharmacokinetic calculations were performed for each treated animal using an open one-compartment-model with first-order elimination after SC dosing. Marbofloxacin in plasma (means): Maximum concentrations (Cmax) of about 1.2 and 3.0 microg/ml were measured 2.3 and 4 hours (tmax) after dosing of 2 and 4 mg/kg BW, respectively. Elimination from the body was low with a total clearance (Cl/F) of approximately 0.1 l/h/kg for both dosages. The half-life (t 1/2) for this process was calculated with 8-10 hours. AUC increased almost proportional when doubling the dose, i.e., 19.77 +/- 6.25 microg * h/ml (2 mg/kg BW) and 51.26 +/- 11.83 microg * h/ml (4 mg/kg BW). Plasma kinetics measured were in accordance with data from literature. Marbofloxacin in urine (means): Maximum drug concentrations were detected 4 and 8 hours after dosing with 70 microg/ml (2 mg/kg BW) and 160 microg/ml (4 mg/kg BW), respectively. Inhibitory effects of the urinary matrix on the antimicrobial activity of the drug were taken into account when performing PK/PD calculations. However, a concentration-dependent bactericidal activity (Cmax/MIC > 8-10) which is claimed for fluoroquinolones was sufficiently met with focus on Escherichia (E.) coli (MIC90 0.5 microg/ml). In the same matrix a threshold value of 1.0 microg/ml was undercut 82 and 116 hours after SC dosing, respectively. Hence, a time-dependent bacteria killing kinetic (T > MIC) which may be of relevance for some Gram-positive germs like Staphylococcus spp. (MIC90 1.0 microg/ml) should be covered, too.


Assuntos
Antibacterianos/farmacocinética , Gatos/metabolismo , Fluoroquinolonas/farmacocinética , Animais , Antibacterianos/administração & dosagem , Antibacterianos/sangue , Antibacterianos/urina , Área Sob a Curva , Gatos/sangue , Gatos/urina , Fluoroquinolonas/administração & dosagem , Fluoroquinolonas/sangue , Fluoroquinolonas/urina , Meia-Vida , Injeções Subcutâneas/veterinária , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...